TalkMed Group Limited (SGX:5G3)

Market Cap	591.98M
Revenue (ttm)	78.18M
Net Income (ttm)	43.79M
Shares Out	1.33B
EPS (ttm)	0.03
PE Ratio	13.61
Forward PE	n/a
Dividend	0.02 (5.11%)
Ex-Dividend Date	Aug 14, 2024

Volume	n/a
Average Volume	19,740
Open	0.4500
Previous Close	0.4500
Day's Range	0.4500 - 0.4500
52-Week Range	0.3800 - 0.5000
Beta	0.03
RSI	46.50
Earnings Date	Jul 15, 2025

About TalkMed Group

TalkMed Group Limited, an investment holding company, provides medical oncology, stem cell transplants, palliative care, and other related services in Singapore, China, Hong Kong, Vietnam, New Zealand, Australia, and the United States. It operates in two segments: Oncology Services; and Cellular and Gene Therapy Related Products and Services. The company offers medical oncology services in the areas of breast, colon, lung, liver, biliary and pancreatic, gastro-intestinal, head and neck, genitourinary and gynaecological, and haematology malignan...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1997
• Employees: 235
• Stock Exchange: Singapore Exchange
• Ticker Symbol: 5G3

Financial Performance

In 2024, TalkMed Group's revenue was 78.18 million, a decrease of -6.70% compared to the previous year's 83.79 million. Earnings were 43.79 million, an increase of 36.10%.